Moderna is an mRNA therapeutics company that rose to prominence with its COVID-19 vaccine. Built on foundational research by Katalin Kariko and Drew Weissman, it is advancing an mRNA pipeline spanning infectious disease, oncology, rare diseases, and autoimmune conditions.
R&D SPEND
$4.8B
INDUSTRY
Biotech
280
ACADEMIC COLLABORATIONS
2800
PATENTS
TRY IT
Install the CLI and run your first search in under a minute. No account required to explore.
npx sci-buy@latest COPIED